Post-effective amendment to a registration statement that is not immediately effective upon filing

Income Taxes (Tables)

v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Taxes  
Summary of components of the Company's loss before income tax expense

The components of the Company’s loss before income tax expense are as follows (in thousands):

Year Ended December 31, 

    

2021

    

2020

United States

$

(10,400)

$

(27,066)

Foreign

 

(458)

 

(326)

Loss before income tax provision

$

(10,858)

$

(27,392)

Summary of reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate

Year Ended December 31,

    

2021

    

2020

Federal statutory income tax rate

21.0

%

21.0

%

State income taxes, net of federal benefit

18.8

3.9

Federal and state research and development tax credits

9.7

7.3

Loss on extinguishment of debt

(24.5)

0

Merger transaction costs

(1.3)

0

Change in fair value of contingent earn-out liability and contingently issuable common stock liability

124.5

0

Change in fair value of derivative liability

(3.4)

0

Non-deductible convertible notes interest

(10.2)

0

Change in valuation allowance

(138.1)

(33.7)

Change in tax rate

(0.5)

1.3

Stock-based compensation

4.3

0

Permanent differences

(0.4)

(0.3)

Other

0.1

0.5

Effective income tax rate

(0.0)

%

(0.0)

%

Summary of net deferred tax assets

Net deferred tax assets consisted of the following (in thousands):

December 31, 

    

2021

    

2020

Deferred tax assets:

 

  

 

  

Net operating loss carryforwards

$

25,357

$

13,996

Research and development tax credit carryforwards

 

4,910

 

3,857

Capitalized research and development costs

 

8,473

 

7,274

Accrued expenses

 

3,211

 

334

Deferred revenue

 

2,293

 

1,049

Other

 

43

 

304

Total deferred tax assets

 

44,287

 

26,814

Valuation allowance

 

(43,407)

 

(26,005)

Total deferred tax assets, net of valuation allowance

 

880

 

809

Deferred tax liabilities:

 

  

 

  

Depreciation and amortization

 

(864)

 

(542)

Other

 

(16)

 

(267)

Total deferred tax liabilities

 

(880)

 

(809)

Net deferred tax assets

$

$

Summary of changes in the valuation allowance for deferred tax assets

Changes in the valuation allowance for deferred tax assets related primarily to the increase in net operating loss carryforwards, research and development tax credit carryforwards, and capitalized R&D costs and were as follows (in thousands):

December 31, 

    

2021

    

2020

Valuation allowance as of beginning of year

 

$

26,005

$

16,767

Additions charged to provision for income taxes

 

15,245

 

9,233

Additions charged to equity

2,155

Currency translation and other

 

2

 

5

Valuation allowance as of end of year

$

43,407

$

26,005